CC
CNST

Casdin Capital’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Casdin Capital’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,341,000
Closed -$45.3M – 62
2021
Q2 		$45.3M Sell
1,341,000
-459,000
-26% -$11.7M 1.15% 25
2021
Q1 		$42.1M Buy
1,800,000
+15,000
+0.8% +$454K 1.25% 22
2020
Q4 		$51.4M Buy
1,785,000
+805,000
+82% +$20.3M 1.52% 16
2020
Q3 		$19.9M Hold
980,000
– – 0.89% 27
2020
Q2 		$29.4M Hold
980,000
– – 1.74% 19
2020
Q1 		$30.8M Sell
980,000
-232,734
-19% -$8.09M 3.27% 10
2019
Q4 		$57.1M Sell
1,212,734
-311,226
-20% -$8.99M 5.25% 8
2019
Q3 		$9.84M Hold
1,523,960
– – 1.02% 26
2019
Q2 		$18.7M Sell
1,523,960
-33,039
-2% -$368K 1.75% 20
2019
Q1 		$21.1M Buy
1,556,999
+1
+0% +$9 2.32% 17
2018
Q4 		$6.24M Buy
1,556,998
+242,255
+18% +$1.46M 1.07% 26
2018
Q3 		$8.85M Buy
+1,314,743
New +$12.5M 1.08% 25

Casdin Capital's CNST Position: Q3 2021 in Review

Casdin Capital sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,341,000 shares — an estimated $45.3M sold.

Casdin Capital first reported a position in CNST in Q3 2018 and held it in 12 quarters. The position peaked at $57.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Casdin Capital reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Casdin Capital sold 1,341,000 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $45.3M.
  • Casdin Capital first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 12 quarters.
  • Casdin Capital's Constellation Pharmaceuticals, Inc. position peaked at $57.1M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Casdin Capital's 13F filing for Q3 2021, filed 15 Nov 2021.